Virology
Learning Objectives
By the end of this chapter, you should be able to:
- Describe the structural components of a virus and explain how structure determines classification (Baltimore system).
- Outline the seven steps of the viral replication cycle and identify where common antivirals act.
- Differentiate the major DNA and RNA virus families and name at least one clinically important pathogen from each.
- Explain the HIV replication cycle and the mechanism of action of each major antiretroviral drug class.
- Distinguish hepatitis A, B, C, D, and E by transmission route, chronicity risk, and serologic markers.
- Explain influenza antigenic drift versus antigenic shift and why each matters for vaccine strategy and pandemic risk.
- Identify common student misconceptions about viruses and correct them with mechanistic reasoning.
Quick Answer
Virology is the study of viruses — infectious particles made of nucleic acid (DNA or RNA, never both) wrapped in a protein capsid, sometimes surrounded by a lipid envelope. Viruses cannot replicate on their own; they hijack a host cell's ribosomes and enzymes to make copies of themselves. This matters clinically because a virus's genome type and replication strategy dictate which drugs can work against it, how it evades immunity, and how it spreads. Virology underpins the diagnosis and management of diseases from the common cold to HIV/AIDS, hepatitis, and influenza pandemics, and it drives vaccine and antiviral drug development — the two most powerful tools medicine has against viral disease.
Overview
A virus is the smallest infectious agent you will study, and also the strangest. It has no cytoplasm, no ribosomes, no metabolism of its own — by most definitions of "life," a virus outside a cell is just an inert particle. Yet once it gets inside a susceptible cell, it reprograms that cell's machinery to produce hundreds of new viral copies. This obligate intracellular parasitism is the single fact that explains almost everything else about viruses: why antibiotics (which target bacterial machinery) are useless against them, why antivirals are hard to design without harming the host cell, and why the immune system's antiviral strategies (interferons, cytotoxic T cells) focus on detecting and killing infected cells rather than just neutralizing free particles.
Clinically, virology matters because viruses cause an enormous share of human disease — from self-limited infections like the common cold to life-changing chronic infections like HIV and hepatitis B/C, to pandemic threats like influenza and SARS-CoV-2. Understanding a virus's structure and replication strategy is not academic trivia — it is what tells you whether a vaccine is feasible, whether an antiviral drug exists, and why some viral infections become chronic while others clear completely.
Viral Structure and Classification
Structure
Every virus has two non-negotiable components:
- Genome: either DNA or RNA (never both), which can be single-stranded (ss) or double-stranded (ds), and linear or circular.
- Capsid: a protein shell built from repeating subunits called capsomeres, arranged in either helical symmetry (e.g., rabies, influenza) or icosahedral symmetry (e.g., adenovirus, poliovirus).
The genome plus capsid together are called the nucleocapsid. Some viruses stop there ("naked" viruses, e.g., poliovirus, adenovirus) — these tend to be more stable in the environment and resistant to drying, detergents, and stomach acid, which is why many naked viruses spread by the fecal-oral route. Other viruses acquire an envelope, a lipid bilayer stolen from the host cell membrane (or nuclear membrane) during budding, studded with viral glycoproteins used for attachment (e.g., HIV gp120, influenza hemagglutinin). Enveloped viruses are fragile — destroyed by soap, heat, and desiccation — which is why hand-washing is so effective against enveloped respiratory and enteric viruses, and why they typically require direct contact, respiratory droplets, or blood/body fluid exposure to spread.
Classification: the Baltimore system
The most exam-relevant classification is the Baltimore classification, which groups viruses by genome type and how that genome gets converted into messenger RNA (mRNA) — because the ribosome can only read mRNA.
| Class | Genome | Example |
|---|---|---|
| I | dsDNA | Herpesviruses, adenovirus, poxvirus |
| II | ssDNA | Parvovirus B19 |
| III | dsRNA | Rotavirus |
| IV | ssRNA (+), acts directly as mRNA | Poliovirus, hepatitis A/C, coronaviruses |
| V | ssRNA (−), must be transcribed to mRNA | Influenza, rabies, measles |
| VI | ssRNA, reverse-transcribed to DNA (retrovirus) | HIV |
| VII | dsDNA, reverse-transcribed through an RNA intermediate | Hepatitis B |
The practical payoff: a positive-sense RNA genome is immediately infectious if you inject naked viral RNA into a cell (it works as mRNA on its own), whereas a negative-sense RNA genome is not infectious by itself — the virion must carry its own RNA-dependent RNA polymerase to make the first mRNA strand. This is a favorite exam distinction.
Viral Replication Cycle
Regardless of the virus family, replication follows the same seven-step logic. This is the single most testable concept in virology because every antiviral drug class targets one specific step.
A few details worth locking in:
- DNA viruses (except poxvirus) replicate in the host nucleus, hijacking host DNA polymerase — this is why they depend heavily on the host cell being in S-phase, and why some DNA viruses (herpesviruses, HPV, HBV) can push cells into the cycle or integrate and cause cancer.
- RNA viruses (except retroviruses and orthomyxoviruses like influenza) replicate entirely in the cytoplasm, because they carry or make their own RNA-dependent RNA polymerase — an enzyme human cells don't normally have, which makes it an attractive drug target.
- Retroviruses (HIV) are the exception within RNA viruses: they reverse-transcribe their RNA into DNA and integrate it into the host genome, which is why HIV infection is permanently incurable with current therapy — the integrated provirus becomes part of the cell's own DNA.
- Naked viruses typically kill the cell (lysis) to release progeny; enveloped viruses usually bud gradually from the cell surface without necessarily killing it immediately, allowing prolonged, low-level shedding — a key reason HIV and hepatitis B/C can cause chronic, persistent infection.
Major Viral Pathogens
DNA Viruses
| Family | Key example | Clinical relevance |
|---|---|---|
| Herpesviridae | HSV-1/2, VZV, EBV, CMV | Latency in neurons (HSV, VZV) or lymphocytes (EBV, CMV); reactivation under immunosuppression |
| Hepadnaviridae | Hepatitis B virus | Chronic hepatitis, cirrhosis, hepatocellular carcinoma; only DNA virus with reverse transcriptase |
| Papillomaviridae | HPV 16/18 (high-risk), 6/11 (low-risk) | Cervical, anal, oropharyngeal cancer; genital warts; prevented by vaccination |
| Adenoviridae | Adenovirus | Conjunctivitis, pharyngitis, gastroenteritis; naked, very stable |
| Parvoviridae | Parvovirus B19 | Erythema infectiosum ("slapped cheek"), aplastic crisis in sickle cell disease |
RNA Viruses
| Family | Key example | Clinical relevance |
|---|---|---|
| Orthomyxoviridae | Influenza A/B | Seasonal epidemics and pandemics; segmented genome enables reassortment |
| Flaviviridae | Hepatitis C, dengue, Zika | HCV causes chronic hepatitis and cirrhosis; arboviruses cause hemorrhagic fever |
| Retroviridae | HIV-1/2 | Progressive CD4 T-cell depletion, AIDS |
| Picornaviridae | Poliovirus, hepatitis A, rhinovirus | Fecal-oral or respiratory spread; HAV never becomes chronic |
| Paramyxoviridae | Measles, mumps, RSV | Highly contagious respiratory droplet spread; measles has one of the highest R0 values known |
| Coronaviridae | SARS-CoV-2 | Respiratory pandemic pathogen; spike protein mediates ACE2 binding |
Deep dive: HIV replication and antiretroviral drugs
HIV is worth knowing step-by-step because every major antiretroviral drug class corresponds directly to one stage of its life cycle:
- Attachment/entry: gp120 binds CD4, then a co-receptor (CCR5 or CXCR4) — blocked by entry/fusion inhibitors (maraviroc, enfuvirtide).
- Reverse transcription: viral RNA is converted to dsDNA by reverse transcriptase — blocked by NRTIs (tenofovir, lamivudine) and NNRTIs (efavirenz).
- Integration: viral DNA is spliced into the host genome by integrase — blocked by integrase strand-transfer inhibitors (dolutegravir, raltegravir).
- Transcription/translation: host machinery makes a long polyprotein.
- Assembly/maturation: HIV protease cleaves the polyprotein into functional structural proteins — blocked by protease inhibitors (ritonavir, lopinavir).
Modern therapy combines drugs from at least two classes ("highly active antiretroviral therapy," HAART) to suppress the virus below detectable levels and prevent resistance, since HIV's error-prone reverse transcriptase generates huge genetic diversity within a single patient.
Deep dive: the hepatitis viruses compared
Students frequently mix these up. The organizing question is always: fecal-oral or blood-borne, and does it become chronic?
| Virus | Genome | Transmission | Chronic infection? | Key marker |
|---|---|---|---|---|
| Hepatitis A | ssRNA (+) | Fecal-oral | Never | IgM anti-HAV (acute) |
| Hepatitis B | Partially dsDNA | Blood, sexual, perinatal | Yes (~5-10% of adults, up to 90% of neonates) | HBsAg (infection), anti-HBs (immunity), HBeAg (active replication) |
| Hepatitis C | ssRNA (+) | Blood (needles, transfusion pre-1992) | Yes (~75-85%) | Anti-HCV antibody + HCV RNA (confirms active infection) |
| Hepatitis D | ssRNA, defective | Blood/sexual, only with HBV | Worsens HBV outcomes | Requires HBsAg to co-infect or superinfect |
| Hepatitis E | ssRNA (+) | Fecal-oral (contaminated water) | Rarely, except immunosuppressed | High mortality in pregnant women |
Deep dive: influenza antigenic drift vs. antigenic shift
Influenza's segmented, negative-sense RNA genome (8 separate segments) makes it a master of immune evasion in two distinct ways:
- Antigenic drift: small point mutations accumulate in hemagglutinin (HA) and neuraminidase (NA) genes due to the error-prone viral RNA polymerase, gradually changing the proteins the immune system recognizes. This is why last year's flu vaccine gives weaker protection this year, and why the vaccine composition is updated annually. Drift causes seasonal epidemics.
- Antigenic shift: an abrupt, major change that occurs when two different influenza strains (e.g., a human and an avian strain) co-infect the same cell — often a pig, which has receptors for both — and their segmented genomes reassort, mixing whole gene segments to produce a novel HA or NA subtype. Because almost no one has prior immunity to the new subtype, shift can cause pandemics (e.g., 2009 H1N1). Shift only happens in influenza A, because only influenza A infects multiple species and has the reassortment opportunity that comes with a broad host range.
Antiviral Drugs
Antivirals are harder to design than antibiotics because viruses use host-cell machinery for most steps — a drug that stops viral replication risks stopping the host cell too. Effective antivirals therefore target the few genuinely viral-specific enzymes or structures.
| Drug class | Target step | Mechanism | Example |
|---|---|---|---|
| Nucleoside/nucleotide analogs | Genome replication | Incorporated into growing viral DNA/RNA, causing chain termination | Acyclovir (HSV), tenofovir (HIV/HBV) |
| Neuraminidase inhibitors | Release | Block neuraminidase, so new virions stay stuck to the infected cell surface | Oseltamivir (influenza) |
| Protease inhibitors | Assembly/maturation | Prevent cleavage of polyprotein into functional viral proteins | Ritonavir (HIV), nirmatrelvir (SARS-CoV-2) |
| Integrase inhibitors | Integration | Block insertion of viral DNA into host genome | Dolutegravir (HIV) |
| Entry/fusion inhibitors | Attachment/penetration | Block receptor binding or membrane fusion | Maraviroc, enfuvirtide (HIV) |
| Interferons | Broad, host-mediated | Boost the host's own antiviral state (upregulate antiviral proteins in neighboring cells) | Pegylated interferon-alfa (chronic HBV/HCV, historically) |
Key Terms
| Term | Definition |
|---|---|
| Capsid | The protein shell, built from capsomeres, that encloses and protects the viral genome |
| Envelope | A lipid bilayer, derived from host membrane, that surrounds some viruses and carries viral glycoproteins |
| Nucleocapsid | Genome plus capsid together, before any envelope is added |
| Baltimore classification | A system grouping viruses by genome type (DNA/RNA, single/double-stranded, sense) and mRNA synthesis strategy |
| Positive-sense RNA | RNA genome that can act directly as mRNA and is immediately translatable |
| Negative-sense RNA | RNA genome that must first be transcribed into a complementary strand before it can be translated |
| Reverse transcriptase | A viral enzyme that synthesizes DNA from an RNA template; defines retroviruses and hepatitis B |
| Latency | A dormant state in which viral genome persists in a host cell without producing new virions (e.g., herpesviruses) |
| Antigenic drift | Gradual accumulation of point mutations in surface antigens, causing seasonal immune escape |
| Antigenic shift | Abrupt reassortment of gene segments between two influenza strains, producing a novel subtype |
| Reassortment | Mixing of genome segments when two viral strains co-infect the same host cell (relevant to segmented genomes) |
| Provirus | Viral DNA integrated into the host cell genome, as occurs with retroviruses |
Common Mistakes
Misconception 1: "Antibiotics can be used against bad viral infections if the antiviral isn't working." Why it's wrong: Antibiotics target bacterial-specific structures — the cell wall (penicillins), bacterial ribosomes (macrolides, aminoglycosides), or bacterial DNA gyrase (fluoroquinolones). Viruses have no cell wall, no independent ribosomes, and no bacterial-type gyrase. Correct explanation: Antibiotics have zero activity against viruses. Giving them for viral infections doesn't help the patient and drives antibiotic resistance in the patient's bacterial flora. The only exception is treating a secondary bacterial infection that develops on top of a viral one (e.g., bacterial pneumonia after influenza).
Misconception 2: "All viruses replicate inside the nucleus." Why it's wrong: Students generalize from DNA viruses, which do use the nucleus (to access host DNA polymerase), and assume it applies universally. Correct explanation: Most RNA viruses replicate entirely in the cytoplasm because they bring or synthesize their own RNA-dependent RNA polymerase. Exceptions worth remembering: poxviruses (DNA virus that replicates in the cytoplasm because it carries its own transcription machinery) and influenza/retroviruses (RNA viruses that must enter the nucleus, because influenza's polymerase needs to "steal" caps from host mRNA and retroviruses need host machinery to integrate their DNA).
Misconception 3: "A person who clears an acute hepatitis B infection is not at risk anymore, and hepatitis serology is basically the same for all hepatitis viruses." Why it's wrong: This conflates hepatitis A (never chronic) with hepatitis B, which can become chronic in adults and especially in perinatally infected infants, and ignores that HBV serologic markers (HBsAg, anti-HBs, HBeAg, anti-HBc) each mean something different, unlike the simpler IgM/IgG pattern used for HAV. Correct explanation: Chronicity risk and the right test both depend on the specific hepatitis virus and, for HBV, the age at infection. A cleared HBV infection shows anti-HBs and anti-HBc (without HBsAg); ongoing infection shows persistent HBsAg. Always match the test panel to the specific virus being asked about.
Comparison and Connections
| Feature | Naked (non-enveloped) viruses | Enveloped viruses |
|---|---|---|
| Outer layer | Capsid only | Capsid + lipid envelope with glycoproteins |
| Environmental stability | High — resists drying, acid, detergents | Low — destroyed by soap, heat, desiccation |
| Typical transmission | Fecal-oral, fomites | Respiratory droplets, blood, sexual contact, direct contact |
| Release from cell | Usually lysis (kills cell) | Usually budding (cell may survive, enabling chronic shedding) |
| Examples | Poliovirus, adenovirus, hepatitis A, HPV | Influenza, HIV, hepatitis B/C, herpesviruses, coronaviruses |
| Feature | DNA viruses (Class I/II) | RNA viruses (Class III-V) | Retroviruses (Class VI) |
|---|---|---|---|
| Replication site | Nucleus (usually) | Cytoplasm (usually) | Nucleus (integration required) |
| Polymerase used | Host DNA polymerase | Viral RNA-dependent RNA polymerase | Reverse transcriptase (viral) |
| Mutation rate | Low (host proofreading) | High (no proofreading) | Very high |
| Cure potential | Possible to clear (except latent forms) | Often clearable (acute) | Not curable — genome integrates permanently |
Practice Questions
Recall 1. What are the two components every virus must have, regardless of family? Answer guidance: Genome (DNA or RNA) and capsid (protein coat); together they form the nucleocapsid.
Recall 2. Name the enzyme unique to retroviruses that converts RNA into DNA. Answer guidance: Reverse transcriptase.
Understanding 1. Explain why negative-sense RNA viruses must carry their own RNA-dependent RNA polymerase inside the virion, while positive-sense RNA viruses do not need to. Answer guidance: Positive-sense RNA can be read directly by host ribosomes as if it were mRNA, so translation can start immediately. Negative-sense RNA is the complement of mRNA and cannot be translated directly; the virus must first transcribe it into a readable positive-sense strand, which requires the polymerase to already be present at the moment of infection — it cannot be made from the negative-sense genome alone without it.
Understanding 2. Explain, in mechanistic terms, why enveloped viruses are more susceptible to soap and disinfectants than naked viruses. Answer guidance: The envelope is a lipid bilayer; soap and alcohol-based disinfectants dissolve lipids, disrupting the envelope and destroying the glycoproteins needed for attachment. Naked viruses have only a protein capsid, which is far more resistant to lipid solvents, so they survive longer on surfaces and require different disinfection (e.g., bleach) and different hygiene precautions (e.g., hand-washing over sanitizer for norovirus).
Application 1. A patient with chronic hepatitis C is being counseled about how the infection can persist for decades. Using what you know about enveloped virus release, explain how HCV can maintain a low-grade, ongoing infection without immediately destroying the liver. Answer guidance: HCV is enveloped and typically buds from hepatocytes rather than lysing them outright, allowing continuous low-level virion release while the host cell survives. Combined with HCV's high mutation rate (RNA polymerase lacks proofreading), the virus can also evade antibody responses by generating new epitope variants, helping it persist rather than being cleared.
Application 2. A patient recovers from seasonal flu in one year but gets infected again by influenza the following year, despite having a "normal" immune response the first time. Using antigenic drift, explain why annual reinfection is expected rather than a sign of immune deficiency. Answer guidance: Influenza's error-prone RNA polymerase introduces point mutations in HA and NA each season (antigenic drift). The antibodies made against last year's strain no longer bind well to this year's slightly altered surface proteins, so the immune system doesn't recognize the new variant quickly enough to prevent infection — this is why the vaccine composition changes yearly and reinfection is expected, not abnormal.
Analysis 1. Compare and contrast antigenic drift and antigenic shift in terms of mechanism, which influenza types they occur in, and their public health consequences. Answer guidance: Drift is due to accumulated point mutations in HA/NA and occurs in both influenza A and B; it causes gradual immune escape and seasonal epidemics. Shift is due to reassortment of whole gene segments between two co-infecting influenza strains (requires a segmented genome and a mixing host such as swine), occurs only in influenza A (because only A has the multi-species host range needed for co-infection with divergent strains), and can produce a wholly novel HA/NA subtype against which the population has little pre-existing immunity — creating pandemic potential rather than just a bad season.
Analysis 2. A student argues that because HIV and HBV are unrelated viruses (one is an RNA retrovirus, the other a DNA hepadnavirus), they should have nothing in common mechanistically. Evaluate this claim. Answer guidance: The claim is incorrect. Despite differing genome types, both HIV and HBV use reverse transcriptase as an essential step in their replication cycle — HBV is actually classified as a DNA virus that replicates through an RNA intermediate (Class VII), the reverse process of HIV's RNA-to-DNA strategy. This shared enzyme is why some antiretroviral drugs (e.g., tenofovir, lamivudine) are active against both HIV and HBV, and why patients co-infected with both need careful drug selection to avoid inadequate treatment of either virus.
FAQ
Q1: Are viruses alive? Not by most definitions. They have no independent metabolism, cannot reproduce without a host cell, and outside a cell are biochemically inert particles. They occupy a gray zone between living and non-living — which is exactly why they're studied as their own discipline rather than folded into bacteriology.
Q2: Why don't antibiotics work on viruses? Antibiotics target structures unique to bacteria — cell walls, bacterial ribosomes, bacterial enzymes like DNA gyrase. Viruses lack all of these and instead hijack the host's own human cell machinery, which antibiotics are not designed to disrupt.
Q3: Why is HIV incurable while hepatitis C can now be cured? HIV integrates its reverse-transcribed DNA permanently into the host genome as a provirus, including in long-lived resting memory T cells, so no current drug can remove it once integrated. Hepatitis C is an RNA virus that does not integrate into host DNA; direct-acting antivirals can now clear essentially all traces of the virus from the body, achieving a true cure in the vast majority of patients.
Q4: Why do some viral infections (like HSV) come back years later? Herpesviruses establish latency — their genome persists quietly inside neurons without actively producing new virions, evading immune detection. Stress, immunosuppression, or UV exposure can trigger reactivation, restarting active replication and causing recurrent lesions (cold sores, shingles).
Q5: How do mRNA vaccines fit into all this if they don't use a live virus at all? mRNA vaccines deliver a synthetic positive-sense mRNA encoding a single viral protein (like the SARS-CoV-2 spike). Host ribosomes translate it exactly the way they'd translate a positive-sense RNA virus's genome, producing the viral protein so the immune system can learn to recognize it — without any viral replication cycle occurring, since only one protein-coding mRNA is delivered, not a full infectious genome.
Quick Revision
- Every virus has a genome (DNA or RNA, never both) plus a capsid; the two together are the nucleocapsid.
- Enveloped viruses are fragile (soap/heat kill them); naked viruses are hardy and often spread fecal-oral.
- Baltimore classification groups viruses by genome type and mRNA strategy — 7 classes, I through VII.
- Positive-sense RNA acts directly as mRNA; negative-sense RNA needs the virion's own polymerase to be transcribed first.
- Replication cycle: attachment, penetration, uncoating, replication/transcription, translation, assembly, release.
- DNA viruses generally replicate in the nucleus; most RNA viruses replicate in the cytoplasm; retroviruses integrate into the nucleus.
- HIV drug classes map directly onto its life cycle: entry inhibitors, NRTIs/NNRTIs, integrase inhibitors, protease inhibitors.
- Hepatitis A and E spread fecal-oral and don't cause chronic infection; hepatitis B, C, and D spread via blood/sexual contact and can become chronic.
- HBsAg means current infection; anti-HBs means immunity (vaccinated or resolved); HBeAg means active viral replication.
- Antigenic drift = gradual point mutations = seasonal flu, needs annual vaccine updates. Antigenic shift = segment reassortment = pandemic potential, only in influenza A.
- Most antivirals target replication-specific viral enzymes (reverse transcriptase, protease, neuraminidase, integrase) to spare host cells.
- Herpesviruses establish latency in neurons; reactivation causes recurrent disease (cold sores, shingles) without new infection.
Related Topics
Prerequisites
- Basic cell biology (nucleus, ribosomes, cell membrane)
- Introduction to microbiology and the classification of microorganisms
- Basic immunology (innate vs. adaptive immunity, antibodies)
Related Topics
- Bacteriology (for contrast with prokaryotic pathogens and antibiotic mechanisms)
- Immunology (interferons, cytotoxic T cells, humoral immunity)
- Epidemiology (outbreak investigation, R0, herd immunity)
Next Topics
- Vaccine development and immunization strategies
- Clinical infectious disease syndromes caused by specific viral pathogens
- Antimicrobial resistance and antiviral drug resistance mechanisms